(WFRF:(Fryknäs Mårten)) srt2:(2020-2024)
Search: (WFRF:(Fryknäs Mårten)) srt2:(2020-2024) > Selective radiosens...
- 10 of 19
- Previous record
- Next record
- To hitlist
Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells
-
- Karlsson, Henning (author)
- Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
-
- Fryknäs, Mårten (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
- Senkowski, Wojciech (author)
- Uppsala Univ, Dept Med Sci, Entrance 61,Sjukhusvagen 9, S-75185 Uppsala, Sweden.
- show more...
- show less...
- (creator_code:org_t)
- 2022-02-17
- 2022
- English.
- In: Oncology Letters. - : Spandidos Publications. - 1792-1074 .- 1792-1082. ; 23:4
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Nitazoxanide is a Food and Drug Administration-approved antiprotozoal drug recently demonstrated to be selectively active against quiescent and glucose-deprived tumour cells. This drug also has several characteristics that suggest its potential as a radiosensitizer. The present study aimed to investigate the interaction between nitazoxanide and radiation on human colon cancer cells cultured as monolayers, and to mimic key features of solid tumours in patients, as spheroids, as well as in xenografts in mice. In the present study, colon cancer HCT116 green fluorescent protein (GFP) cells were exposed to nitazoxanide, radiation or their combination. Cell survival was analysed by using total cell kill and clonogenic assays. DNA double-strand breaks were evaluated in the spheroid experiments, and HCT116 GFP cell xenograft tumours in mice were used to investigate the effect of nitazoxanide and radiation in vivo. In the clonogenic assay, nitazoxanide synergistically and selectively sensitized cells grown as spheroids to radiation. However, this was not observed in cells cultured as monolayers, as demonstrated in the total cell kill assays, and much less with the clinically established sensitizer 5-fluorouracil. The sensitizing effect from nitazoxanide was confirmed via spheroid gamma-H2A histone family member X staining. Nitazoxanide and radiation alone similarly inhibited the growth of HCT116 GFP cell xenograft tumours in mice with no evidence of synergistic interaction. In conclusion, nitazoxanide selectively targeted quiescent glucose-deprived tumour cells and sensitized these cells to radiation in vitro. Nitazoxanide also inhibited tumour growth in vivo. Thus, nitazoxanide is a candidate for repurposing into an anticancer drug, including its use as a radiosensitizer.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- nitazoxanide
- spheroid
- 3D
- radiosensitizer
- clonogenic
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Oncology Letters (Search for host publication in LIBRIS)
To the university's database
- 10 of 19
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Karlsson, Hennin ...
- Fryknäs, Mårten
- Senkowski, Wojci ...
- Larsson, Rolf
- Nygren, Peter
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cancer and Oncol ...
- Articles in the publication
- Oncology Letters
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
